These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9816145)
1. Apoptosis loss and bcl-2 expression: key determinants of lymph node metastases in T1 breast cancer. Sierra A; Castellsagué X; Tórtola S; Escobedo A; Lloveras B; Peinado MA; Moreno A; Fabra A Clin Cancer Res; 1996 Nov; 2(11):1887-94. PubMed ID: 9816145 [TBL] [Abstract][Full Text] [Related]
2. Apoptotic and mitotic indices predict survival rates in lymph node-negative colon carcinomas. Sinicrope FA; Hart J; Hsu HA; Lemoine M; Michelassi F; Stephens LC Clin Cancer Res; 1999 Jul; 5(7):1793-804. PubMed ID: 10430084 [TBL] [Abstract][Full Text] [Related]
3. Correlation of Bcl-2 and p53 expression in primary breast tumors and corresponding metastatic lymph nodes. Arun B; Kilic G; Yen C; Foster B; Yardley D; Gaynor R; Ashfaq R Cancer; 2003 Dec; 98(12):2554-9. PubMed ID: 14669273 [TBL] [Abstract][Full Text] [Related]
4. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up. el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951 [TBL] [Abstract][Full Text] [Related]
5. Apoptosis in breast carcinomas detected with monoclonal antibody to single-stranded DNA: relation to bcl-2 expression, hormone receptors, and lymph node metastases. Frankfurt OS; Robb JA; Sugarbaker EV; Villa L Clin Cancer Res; 1997 Mar; 3(3):465-71. PubMed ID: 9815706 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases. Olopade OI; Adeyanju MO; Safa AR; Hagos F; Mick R; Thompson CB; Recant WM Cancer J Sci Am; 1997; 3(4):230-7. PubMed ID: 9263629 [TBL] [Abstract][Full Text] [Related]
7. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
8. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer. Sjöström-Mattson J; Von Boguslawski K; Bengtsson NO; Mjaaland I; Salmenkivi K; Blomqvist C Acta Oncol; 2009; 48(8):1137-43. PubMed ID: 19863221 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal expression of Bcl-2 and p53 in breast ductal carcinoma. Lee WY; Jin YT; Tzeng CC Anticancer Res; 1996; 16(5A):3007-12. PubMed ID: 8917421 [TBL] [Abstract][Full Text] [Related]
10. Correlation between BRCA1 expression and apoptosis-related biological parameters in sporadic breast carcinomas. Yang Q; Yoshimura G; Nakamura M; Nakamura Y; Suzuma T; Umemura T; Mori I; Sakurai T; Kakudo K Anticancer Res; 2002; 22(6B):3615-9. PubMed ID: 12552965 [TBL] [Abstract][Full Text] [Related]
11. The effect of chemotherapy on Ki-67, Bcl-2 and Bak expression in primary tumors and lymph node metastases of breast cancer. Koda M; Sulkowska M; Kanczuga-Koda L; Tomaszewski J; Kucharczuk W; Lesniewicz T; Cymek S; Sulkowski S Oncol Rep; 2007 Jul; 18(1):113-9. PubMed ID: 17549355 [TBL] [Abstract][Full Text] [Related]
12. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients? Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882 [TBL] [Abstract][Full Text] [Related]
13. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer. Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Huang J; Tan PH; Thiyagarajan J; Bay BH Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061 [TBL] [Abstract][Full Text] [Related]
16. bcl-2 and apoptosis in lymph node positive breast carcinoma. Berardo MD; Elledge RM; de Moor C; Clark GM; Osborne CK; Allred DC Cancer; 1998 Apr; 82(7):1296-302. PubMed ID: 9529021 [TBL] [Abstract][Full Text] [Related]
17. p53 but not bcl-2 immunostaining is predictive of poor clinical complete response to primary chemotherapy in breast cancer patients. Bottini A; Berruti A; Bersiga A; Brizzi MP; Brunelli A; Gorzegno G; DiMarco B; Aguggini S; Bolsi G; Cirillo F; Filippini L; Betri E; Bertoli G; Alquati P; Dogliotti L Clin Cancer Res; 2000 Jul; 6(7):2751-8. PubMed ID: 10914720 [TBL] [Abstract][Full Text] [Related]
18. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas. Soda G; Antonaci A; Bosco D; Nardoni S; Melis M J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183 [TBL] [Abstract][Full Text] [Related]
19. MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome. Graflund M; Sorbe B; Karlsson M Int J Oncol; 2002 May; 20(5):1041-7. PubMed ID: 11956602 [TBL] [Abstract][Full Text] [Related]
20. Apoptosis-related proteins (Fas, Fas ligand, bcl-2 and p53) in different types of human breast tumors. Ben-Hur H; Mordechay E; Halperin R; Gurevich P; Zandbank J; Herper M; Zusman I Oncol Rep; 2002; 9(5):977-80. PubMed ID: 12168058 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]